Akili Grabs CE Mark for Children’s Digital ADHD Treatment Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The FDA last week cleared EndeavorRx for marketing in the U.S. Source: Devices & Diagnostics Letter You Might Also Like Trump Criticizes FDA Delay of Convalescent Plasma EUA August 20, 2020 Glenmark’s Favipiravir Shows Promise for COVID-19 Patients July 22, 2020 Glenmark Pharmaceuticals Gets Indian Approval for Favipiravir as a COVID-19 Treatment June 22, 2020
